Get started
BioLife Solutions, Inc.BioLife Solutions, Inc.BioLife Solutions, Inc.

BioLife Solutions, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

BLFS chart


Full chart

BLFS upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.22 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.82 USD
Net income (FY)
‪−66.43 M‬ USD
Revenue (FY)
‪143.27 M‬ USD
Shares float
‪45.21 M‬
Beta (1Y)
1.79

Employees


Employees (FY)
414
Change (1Y)
−53 −11.35%
Revenue / Employee (1Y)
‪346.07 K‬ USD
Net income / Employee (1Y)
‪−160.45 K‬ USD

About BioLife Solutions, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Roderick de Greef
Website
biolifesolutions.com
Headquarters
Bothell
Founded
1987
FIGI
BBG000HRJ8Q5
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

BLFS news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BLFS is 26.50 USD — it has decreased by −3.69% in the past 24 hours. Watch BioLife Solutions, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BioLife Solutions, Inc. stocks are traded under the ticker BLFS.
BLFS stock has fallen by −1.46% compared to the previous week, the month change is a 2.53% rise, over the last year BioLife Solutions, Inc. has showed a 66.67% increase.
We've gathered analysts' opinions on BioLife Solutions, Inc. future price: according to them, BLFS price has a max estimate of 33.00 USD and a min estimate of 27.00 USD. Watch BLFS chart and read a more detailed BioLife Solutions, Inc. stock forecast: see what analysts think of BioLife Solutions, Inc. and suggest that you do with its stocks.
BLFS reached its all-time high on Nov 5, 1991 with the price of 1,382.50 USD, and its all-time low was 0.14 USD and was reached on Oct 10, 2008. View more price dynamics on BLFS chart.
See other stocks reaching their highest and lowest prices.
BLFS stock is 9.48% volatile and has beta coefficient of 1.79. Track BioLife Solutions, Inc. stock price on the chart and check out the list of the most volatile stocks — is BioLife Solutions, Inc. there?
Today BioLife Solutions, Inc. has the market capitalization of ‪1.22 B‬, it has increased by 2.09% over the last week.
Yes, you can track BioLife Solutions, Inc. financials in yearly and quarterly reports right on TradingView.
BioLife Solutions, Inc. is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
BLFS earnings for the last quarter are −0.04 USD per share, whereas the estimation was −0.08 USD resulting in a 48.94% surprise. The estimated earnings for the next quarter are −0.08 USD per share. See more details about BioLife Solutions, Inc. earnings.
BioLife Solutions, Inc. revenue for the last quarter amounts to ‪30.57 M‬ USD, despite the estimated figure of ‪25.54 M‬ USD. In the next quarter, revenue is expected to reach ‪21.73 M‬ USD.
BLFS net income for the last quarter is ‪−1.70 M‬ USD, while the quarter before that showed ‪−11.82 M‬ USD of net income which accounts for 85.59% change. Track more BioLife Solutions, Inc. financial stats to get the full picture.
No, BLFS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 414.00 employees. See our rating of the largest employees — is BioLife Solutions, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioLife Solutions, Inc. EBITDA is ‪−18.43 M‬ USD, and current EBITDA margin is −31.58%. See more stats in BioLife Solutions, Inc. financial statements.
Like other stocks, BLFS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioLife Solutions, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioLife Solutions, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioLife Solutions, Inc. stock shows the buy signal. See more of BioLife Solutions, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.